Caitong International Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9K Buy
+179
New +$19.5K ﹤0.01% 893
2025
Q4
Sell
-118
Closed -$7.37K 2063
2025
Q3
$7.37K Hold
118
0.01% 1109
2025
Q2
$6.14K Sell
118
-34
-22% -$1.52K ﹤0.01% 933
2025
Q1
$6.47K Sell
152
-1,638
-92% -$70.7K ﹤0.01% 961
2024
Q4
$54.7K Buy
+1,790
New +$50.4K 0.05% 447

Other funds holding GH

Caitong International Asset Management's GH Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Guardant Health (GH) in Q2 2026: 179 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #893 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in GH as recently as Q3 2025.

Caitong International Asset Management first reported a position in GH in Q4 2024 and has held it in 5 quarters since. The position peaked at $54.7K in Q4 2024. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Caitong International Asset Management held 179 shares of Guardant Health worth $26.9K as of Q2 2026.
  • Guardant Health was a new Caitong International Asset Management position in Q2 2026.
  • Guardant Health made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #893 holding.
  • Caitong International Asset Management first reported a position in Guardant Health in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Guardant Health position peaked at $54.7K in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.